{
    "Trade/Device Name(s)": [
        "RapidVue hCG Test"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K102175",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020799"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JHI"
    ],
    "Summary Letter Date": "July 30, 2010",
    "Summary Letter Received Date": "August 2, 2010",
    "Submission Date": "August 23, 2010",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (hCG) Test System"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Human Chorionic Gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "Lateral-flow"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test",
        "Dipstick"
    ],
    "Document Summary": "FDA 510(k) summary for RapidVue hCG immunoassay dipstick test for qualitative detection of hCG in urine for early pregnancy detection",
    "Indications for Use Summary": "Qualitative detection of human Chorionic Gonadotropin (hCG) in urine for early detection of pregnancy, intended for use by health care professionals",
    "fda_folder": "Clinical Chemistry"
}